Publication:
Tear function and ocular surface changes with topical mitomycin (MMC) treatment for primary corneal intraepithelial neoplasia

dc.contributor.authorShimazaki, Jun
dc.contributor.authorTsubota, Kazuo
dc.contributor.authorGül, Murat
dc.contributor.buuauthorDoǧru, Murat
dc.contributor.buuauthorErtürk, Haluk
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentGöz Hastalıkları Ana Bilim Dalı
dc.contributor.scopusid7006540932
dc.contributor.scopusid7003716972
dc.date.accessioned2022-03-11T07:46:55Z
dc.date.available2022-03-11T07:46:55Z
dc.date.issued2003-10
dc.descriptionBu çalışma, 6-8 Nisan 2002 tarihleri arasında Ankara[Türkiye]'da düzenlenen 26. Turkish-Ophthalmology-Association-Cornea-Club Meeting'de bildiri olarak sunulmuştur.
dc.description.abstractPurpose: To evaluate the tear function and ocular surface alterations in patients with primary CIN before and after treatment with topical mitomycin (MMC). Patients and Methods. We describe seven patients with unilateral CIN treated with 0.04% topical MMC three times daily until full eradication of the lesion. The patients underwent tear and ocular surface examinations including Cochet-Bonnet corneal sensitivity measurements, tear film break-up time (BUT), Schirmer test, and Rose-Bengal staining before, at the time of resolution of the CIN, and at the final follow-up. Conjunctival impression cytology was performed before treatment and at the last visit. Results: The mean pretreatment corneal sensitivity was 30.3 +/- 7.4 nun and improved to 55 +/- 5 mm at the final visit (P < 0.05). There were no aqueous-deficient eyes. The BUT values and Rose-Bengal staining scores also showed significant improvement at the last follow-up compared with the pretreatment values (P < 0.05). initial impression cytology specimens showed goblet cell loss, higher grades of squamous metaplasia, areas of isolated keratinized, binucleated, and actively mitotic disfigured epithelial cells in all patients. The mean goblet cell density and squamous metaplasia grade were observed to improve significantly at the last visit (P < 0.05). MMC-induced cytologic changes were seen to persist long after cessation of treatment in some patients. All eyes remained free of recurrence and complications during the follow-up period. Conclusion: We found 0.04% topical MMC treatment tid until full eradication to be effective in the management of CIN. The ocular surface disease of CIN was characterized by disturbance of tear film stability, goblet cell loss, and increased squamous metaplasia in all patients. impression cytology proved useful in attaining the diagnosis of CIN, evaluating the effect of treatment, and showing MMC-related long-term changes on the ocular surface.
dc.description.sponsorshipTurkish Ophthalmology Assoc Cornea Club
dc.identifier.citationDoğru, M. vd. (2003). “Tear function and ocular surface changes with topical mitomycin (MMC) treatment for primary corneal intraepithelial neoplasia”. Cornea, 22(7), 627-639.
dc.identifier.endpage639
dc.identifier.issn0277-3740
dc.identifier.issue7
dc.identifier.pubmed14508259
dc.identifier.scopus2-s2.0-0141485294
dc.identifier.startpage627
dc.identifier.urihttps://doi.org/10.1097/00003226-200310000-00007
dc.identifier.urihttp://hdl.handle.net/11452/24945
dc.identifier.volume22
dc.identifier.wos000185577100007
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.collaborationYurt içi
dc.relation.collaborationYurt dışı
dc.relation.journalCornea
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOphthalmology
dc.subjectCorneal intraepithelial neoplasia
dc.subjectMitomycin-c
dc.subjectConjunctival impression cytology
dc.subjectCorneal sensitivity
dc.subjectMalignant epithelial tumors
dc.subjectImpression cytology
dc.subjectSquamous neoplasia
dc.subjectPhototherapeutic
dc.subjectKeratectomy
dc.subjectPterygium surgery
dc.subjectC therapy
dc.subjectEye drops
dc.subjectConjunctival
dc.subjectDysplasia
dc.subject.emtreeMitomycin C
dc.subject.emtreeRose bengal
dc.subject.emtreeAdult
dc.subject.emtreeAged
dc.subject.emtreeArticle
dc.subject.emtreeClinical article
dc.subject.emtreeConjunctiva
dc.subject.emtreeCornea tumor
dc.subject.emtreeDiagnostic value
dc.subject.emtreeDrug effect
dc.subject.emtreeEpithelium cell
dc.subject.emtreeFemale
dc.subject.emtreeFollow up
dc.subject.emtreeGoblet cell
dc.subject.emtreeHuman
dc.subject.emtreeImpression cytology
dc.subject.emtreeLacrimal fluid
dc.subject.emtreeMale
dc.subject.emtreeMitosis
dc.subject.emtreePriority journal
dc.subject.emtreeRecurrence risk
dc.subject.emtreeSchirmer test
dc.subject.emtreeSquamous cell metaplasia
dc.subject.emtreeTear film
dc.subject.meshAdministration, topical
dc.subject.meshAged
dc.subject.meshAntibiotics, antineoplastic
dc.subject.meshCell count
dc.subject.meshConjunctiva
dc.subject.meshCornea
dc.subject.meshCorneal diseases
dc.subject.meshEpithelial cells
dc.subject.meshEye neoplasms
dc.subject.meshFemale
dc.subject.meshFluorescent dyes
dc.subject.meshGoblet cells
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMetaplasia
dc.subject.meshMiddle Aged
dc.subject.meshMitomycin
dc.subject.meshProspective studies
dc.subject.meshRose bengal
dc.subject.meshStaining and labeling
dc.subject.meshTears
dc.subject.scopusConjunctiva; Cancer; Nevus
dc.subject.wosOphthalmology
dc.titleTear function and ocular surface changes with topical mitomycin (MMC) treatment for primary corneal intraepithelial neoplasia
dc.typeArticle
dc.typeProceedings Paper
dc.wos.quartileQ2
dc.wos.quartileQ2
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Göz Hastalıkları Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: